Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution
NCT ID: NCT02728791
Last Updated: 2018-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2016-05-10
2018-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thoracic Bio-reactance Measurement of Cardiac Output in Pulmonary Hypertension
NCT03890627
ClearSight System CHN Study
NCT03807622
Non-Invasive Blood Pressure Monitoring
NCT05825937
Noninvasive Beat-to-Beat ClearSight Blood Pressure Monitoring
NCT02872896
Validation Study in Patients of a Non-invasive Blood Pressure Monitor for Perioperative Use
NCT03795831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a common care ,prospective observational single center study , concerning the results of blood pressure , cardiac output values and their variations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs
* No opposition formulated
Exclusion Criteria
* Pregnant woman
* Refuse to participate
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier O HUET
Role: PRINCIPAL_INVESTIGATOR
CHRU de Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU BREST, Hôpital de la Cavale Blanche
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CONDUCT (RB 15.144)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.